NCT00062348
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +46 more
- Locations
-
- Universitaetsklinikum Essen Essen, Germany
Clinical trial condition
Thyroid Carcinoma, Anaplastic
Explore clinical trials studying Thyroid Carcinoma, Anaplastic. Study availability and eligibility vary by location and protocol.
55 public trials
10 recruiting studies
Thyroid Carcinoma, Anaplastic trial results
NCT00280852
- Conditions
- Anaplastic Thyroid Cancer, Carcinoma, Neoplasms, +3 more
- Locations
-
- Tom Baker Cancer Centre Calgary, Alberta, Canada
NCT00060242
- Conditions
- Carcinoma, Endocrine Gland Neoplasms, Endocrine System Diseases, +9 more
- Locations
-
- Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States
- Ireland Cancer Center at University Hosptials Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States
NCT00005647
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Carcinoma, +38 more
- Locations
-
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
Active, Not Recruiting
Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer
NCT03181100
- Conditions
- Carcinoma, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer
NCT03085056
- Conditions
- Anaplastic Thyroid Cancer, Carcinoma, Neoplasms, +3 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Commack (Limited Protocol Activities) Commack, New York, United States
Active, Not Recruiting
Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer
NCT04238624
- Conditions
- Anaplastic Thyroid Cancer, BRAF Gene Mutation, BRAF Mutation-Related Tumors, +12 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Commack (Limited Protocol Activities) Commack, New York, United States
NCT06790706
- Conditions
- Adenocarcinoma, Anaplastic Thyroid Carcinomas, Carcinoid Tumor, +27 more
- Locations
-
- Institut de Cancerologie de l'Ouest , medical oncology department Angers, France
- Institut Bergonié, medical oncology department Bordeaux, France
- Hospices Civils de Lyon, Thoracic Oncology Department, Louis Pradel Hospital Bron, France
- Centre Hospitalier Universitaire de Lille, medical oncology department Lille, France
Active, Not Recruiting
LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas
NCT03449108
- Conditions
- Adnexal Diseases, Bone Diseases, Bone Neoplasms, +49 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer
NCT04759911
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +25 more
- Locations
-
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
- University of Michigan Health Systems Ann Arbor, Michigan, United States
- M D Anderson Cancer Center Houston, Texas, United States